D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Simmons First National
SFNC
$3.35B
| $576K | ﹤0.01% |
31,308
-198,884
| -86% | -$4.52M |
|
3052
PUT
Arrowhead Research
ARWR
$12.1B
| $575K | ﹤0.01% |
20,000
| – | – |
|
|
FPRX
3053
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $575K | ﹤0.01% |
252,897
-33,199
| -12% | -$141K |
|
3054
Lennar Class B
LEN.B
$20B
| $573K | ﹤0.01% |
20,834
+1,337
| +7% | +$58.4K |
|
3055
CALL
NetApp
NTAP
$32.9B
| $571K | ﹤0.01% |
13,700
-11,300
| -45% | -$584K |
|
3056
CALL
Howmet Aerospace
HWM
$116B
| $570K | ﹤0.01% |
46,292
-88,281
| -66% | -$1.84M |
|
3057
CALL
CDW
CDW
$17.1B
| $569K | ﹤0.01% |
6,100
| – | – |
|
|
SOHU
3058
Sohu.com
SOHU
$336M
| $568K | ﹤0.01% |
91,120
-420,856
| -82% | -$4.19M |
|
3059
PUT
Urban Outfitters
URBN
$5.99B
| $567K | ﹤0.01% |
39,800
-74,800
| -65% | -$1.74M |
|
|
GTHX
3060
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $565K | ﹤0.01% |
+51,283
| New | +$958K |
|
3061
CALL
HF Sinclair
DINO
$15.9B
| $561K | ﹤0.01% |
22,900
-115,800
| -83% | -$4.32M |
|
3062
First Commonwealth Financial
FCF
$2.12B
| $560K | ﹤0.01% |
61,222
-60,702
| -50% | -$751K |
|
3063
1st Source
SRCE
$2.07B
| $560K | ﹤0.01% |
17,270
+10,918
| +172% | +$472K |
|
3064
Southside Bancshares
SBSI
$1.02B
| $558K | ﹤0.01% |
18,364
+10,575
| +136% | +$358K |
|
3065
Teekay Tankers
TNK
$2.63B
| $558K | ﹤0.01% |
+25,075
| New | +$459K |
|
3066
Costamare
CMRE
$1.9B
| $557K | ﹤0.01% |
123,322
+83,566
| +210% | +$599K |
|
|
NBR.PRA
3067
DELISTED
Nabors Industries Ltd. 6.00% Mandatory Convertible Preferred Shares, Series A
NBR.PRA
| $556K | ﹤0.01% |
+135,776
| New | +$2M |
|
|
MDP
3068
DELISTED
Meredith Corporation
MDP
| $555K | ﹤0.01% |
45,457
-90,194
| -66% | -$2.4M |
|
3069
CoreCivic
CXW
$3.1B
| $554K | ﹤0.01% |
49,569
-69,750
| -58% | -$1.04M |
|
3070
Mueller Industries
MLI
$14.1B
| $554K | ﹤0.01% |
92,604
+21,472
| +30% | +$154K |
|
|
TLND
3071
DELISTED
Talend S.A. American Depositary Shares
TLND
| $553K | ﹤0.01% |
24,661
-814
| -3% | -$27.5K |
|
3072
CALL
Bank of Hawaii
BOH
$3.33B
| $552K | ﹤0.01% |
10,000
| – | – |
|
3073
Carriage Services
CSV
$618M
| $551K | ﹤0.01% |
34,111
-43,445
| -56% | -$939K |
|
3074
PUT
Carvana
CVNA
$43.3B
| $551K | ﹤0.01% |
50,000
-25,000
| -33% | -$387K |
|
3075
First Financial Corp
THFF
$922M
| $551K | ﹤0.01% |
16,341
+4,632
| +40% | +$187K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.